Physician profile
Ricardo E Blanco
NPI 1356390371
$17,314.99
in general payments reported to CMS, 2019-2025
26 companies · $1,322 in 2025
The $1,322 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $156 · 2021: $303 · 2022: $594 · 2023: $13K · 2024: $912 · 2025: $1,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $3,000 · Travel and Lodging: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $3,000.32 |
| Travel and Lodging | $583.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,099.56 | 2022-2023 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $705.23 | 2019-2025 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $689.16 | 2019-2025 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $479.47 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $340.61 | 2019-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.13 | 2019-2025 | Ofev |
| United Therapeutics Corporation | $250.86 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $166.17 | 2019-2025 | Winrevair |
| Edwards Lifesciences Corporation | $155.56 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $153.44 | 2023-2025 | Tavneos, Tezspire |
| Genentech USA, INC. | $137.89 | 2019-2021 | |
| Ethicon INC. | $133.16 | 2021 | |
| Viatris Specialty LLC | $132.90 | 2025 | Yupelri |
| Astellas Pharma US INC | $122.81 | 2024 | Cresemba |
| Livanova USA, INC. | $117.31 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $112.82 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $99.39 | 2019-2025 | Dupixent |
| Tempus Ai, INC | $22.46 | 2024 | |
| Jazz Pharmaceuticals INC. | $20.75 | 2019 | |
| Insmed, INC. | $18.23 | 2025 | Arikayce |
| Inogen, INC. | $15.91 | 2025 | |
| Shire North American Group INC | $15.62 | 2019 | |
| Mylan Specialty L.P. | $15.16 | 2019 | |
| Inspire Medical Systems, INC. | $13.38 | 2024 | Inspire |
| Gilead Sciences, INC. | $12.76 | 2019 | |
| Pfizer INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.